Analysis and Perspectives

Mar 24, 2025

Weight loss/Weight management (Obesity) Market is dominated by various treatment approaches including medications, medical devices, apps, and

Mar 14, 2025

80+ pharma companies are working to assess challenges & seek opportunities that could influence obesity treatment scenario in coming years.

Mar 02, 2025

On September 29, 2023, FDA approved EXXUA, the ER gepirone hydrochloride tablets by Fabre-Kramer, for major depressive disorder treatment.

Mar 02, 2025

The major depressive disorder treatment market is expected to surge owing to the launch of novel therapies and key companies in the market.

Feb 15, 2025

In today's highly dynamic and fast-changing market, Competitive Intelligence plays a crucial role in making strategically smart decisions to outsmart the competition

Feb 12, 2025

Donanemab is a promising new Alzheimer’s disease treatment. Donanemab has the potential to rule the Alzheimer’s disease market.

Feb 12, 2025

Despite facing significant setbacks, companies such as Eli Lilly, BioVie, and others are developing effective Alzheimer's disease treatments.

Feb 06, 2025

Polycythemia vera treatment market is expected to substantially change and it will be dominated by approved products, JAKAFI and BESREMi.

Jan 06, 2025

Parkinson's disease treatment market to expand owing to novel therapies being developed by companies such as AZ, Cortexyme, and others.

Nov 29, 2024

The evolving landscape of NSCLC treatment presents significant market opportunities for pharmaceutical companies to secure their place.